BRPI0818511A2 - Novos compostos de miméticos de giro reverso e uso dos mesmos (1) - Google Patents

Novos compostos de miméticos de giro reverso e uso dos mesmos (1)

Info

Publication number: BRPI0818511A2
Authority: BR; Brazil
Prior art keywords: gyretic; mimetics; reverse; new compounds; compounds
Prior art date: 2007-10-15

Application number

BRPI0818511-5A

Other languages

English (en)

Inventor

Jae Uk Chung

Hee-Kyung Jung

Kyung-Yun Jung

Min-Wook Jeong

Hyun-Ju La

Sang-Hak Lee

Hoe-Moon Kim

Original Assignee

Choongwae Pharma Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-10-15

Filing date

2008-10-15

Publication date

2015-06-16

2008-10-15 Application filed by Choongwae Pharma Corp filed Critical Choongwae Pharma Corp

2015-06-16 Publication of BRPI0818511A2 publication Critical patent/BRPI0818511A2/pt

2021-09-21 Publication of BRPI0818511B1 publication Critical patent/BRPI0818511B1/pt

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Orthopedic Medicine & Surgery (AREA)
Immunology (AREA)
Oncology (AREA)
Rheumatology (AREA)
Physical Education & Sports Medicine (AREA)
Hematology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)

BRPI0818511-5A 2007-10-15 2008-10-15 Compostos de miméticos de giro reverso e uso dos mesmos para tratar ou prevenir leucemia mielóide aguda BRPI0818511B1 (pt)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US11/974,941 US7671054B1 (en)	2001-10-12	2007-10-15	Reverse-turn mimetics and method relating thereto
US11/974.941		2007-10-15
PCT/KR2008/006072 WO2009051399A2 (en)	2007-10-15	2008-10-15	Novel compounds of reverse turn mimetics and the use thereof (1)

Publications (2)

Publication Number	Publication Date
BRPI0818511A2 true BRPI0818511A2 (pt)	2015-06-16
BRPI0818511B1 BRPI0818511B1 (pt)	2021-09-21

Family

ID=40567948

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
BRPI0818647-2A BRPI0818647B1 (pt)	2007-10-15	2008-10-15	Compostos de miméticos de volta reversa e uso dos mesmos para tratar ou prevenir leucemia mielóide aguda
BRPI0818511-5A BRPI0818511B1 (pt)	2007-10-15	2008-10-15	Compostos de miméticos de giro reverso e uso dos mesmos para tratar ou prevenir leucemia mielóide aguda

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
BRPI0818647-2A BRPI0818647B1 (pt)	2007-10-15	2008-10-15	Compostos de miméticos de volta reversa e uso dos mesmos para tratar ou prevenir leucemia mielóide aguda

Country Status (13)

Country	Link
US (4)	US7671054B1 (pt)
EP (3)	EP2212329B1 (pt)
JP (3)	JP5222949B2 (pt)
KR (3)	KR101542921B1 (pt)
CN (4)	CN101896485A (pt)
AU (2)	AU2008312191B2 (pt)
BR (2)	BRPI0818647B1 (pt)
CA (2)	CA2702461C (pt)
ES (3)	ES2541459T3 (pt)
MX (2)	MX2010004045A (pt)
PL (1)	PL2212330T3 (pt)
RU (2)	RU2457210C2 (pt)
WO (3)	WO2009051398A2 (pt)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP3211496B2 (ja)	1993-07-30	2001-09-25	日産自動車株式会社	表面潤滑皮膜処理材およびその製造方法
US7671054B1 (en) *	2001-10-12	2010-03-02	Choongwae Pharma Corporation	Reverse-turn mimetics and method relating thereto
US7576084B2 (en) *	2001-10-12	2009-08-18	Choongwae Pharma Corporation	Reverse-turn mimetics and method relating thereto
US7232822B2 (en)	2001-10-12	2007-06-19	Choongwae Pharma Corporation	Reverse-turn mimetics and method relating thereto
US7566711B2 (en) *	2001-10-12	2009-07-28	Choongwae Pharma Corporation	Reverse-turn mimetics and method relating thereto
US8080657B2 (en) *	2001-10-12	2011-12-20	Choongwae Pharma Corporation	Compounds of reverse turn mimetics and the use thereof
US20070129353A1 (en) *	2005-11-08	2007-06-07	Michael Kahn	Alpha-helix mimetics and method relating to the treatment of cancer stem cells
KR101671535B1 (ko) *	2008-06-06	2016-11-01	가부시키가이샤 프리즘 파마	알파 나선 모방체 및 이와 관련된 방법
WO2010044485A1 (en) *	2008-10-14	2010-04-22	Prism Biolab Corporation	Alpha helix mimetics in the treatment of cancer
MX340424B (es) *	2009-04-15	2016-07-08	Jw Pharmaceutical Corp	Compuestos novedosos de mimeticos de cambio inverso; metodo para fabricarlos y su uso.
WO2010128685A1 (en)	2009-05-07	2010-11-11	Prism Biolab Corporation	Alpha helix mimetics and methods relating thereto
WO2011096440A1 (ja)	2010-02-03	2011-08-11	ＰＲＩＳＭＢｉｏＬａｂ株式会社	天然変性タンパク質に結合する化合物およびそのスクリーニング方法
KR102168006B1 (ko)	2010-10-07	2020-10-20	유니버시티 오브 써던 캘리포니아	체세포 줄기 세포의 비대칭 분열을 향상시키기 위한 ｃｂｐ/카테닌 길항제
KR101892575B1 (ko) *	2010-10-14	2018-08-31	제이더블유중외제약 주식회사	리버스-턴 유사체의 신규한 화합물 및 그 제조방법과 용도
BR112013012228B1 (pt)	2010-11-16	2023-02-28	University Of Southern California	Método cosmético para tratar uma condição da pele e usos de um composto antagonista de cbp/catenina de molécula pequena
JP2014509298A (ja) *	2011-02-25	2014-04-17	株式会社ＰＲＩＳＭＰｈａｒｍａ	アルファへリックスミメティック及びその関連の方法
WO2012136492A1 (en) *	2011-04-04	2012-10-11	Siena Biotech S.P.A.	Wnt pathway antagonists
KR101441406B1 (ko) *	2011-05-25	2014-11-04	주식회사 바이오이미징코리아	디아릴이오도늄 염 전구체를 이용한 플로오린-18이 표지된 플루마제닐의 제조 방법
US9353119B2 (en) *	2011-08-09	2016-05-31	Jw Pharmaceutical Corporation	Composition for preventing and treating non-small cell lung cancer, containing pyrazino-triazine derivatives
KR101930859B1 (ko) *	2011-08-09	2018-12-19	제이더블유중외제약 주식회사	피라지노-트리아진 유도체를 포함하는 비소세포성폐암 예방 및 치료용 조성물
KR20140053952A (ko) *	2011-08-26	2014-05-08	제이더블유중외제약 주식회사	피라지노-트리아진 유도체를 포함하는 조성물
AU2012319069A1 (en)	2011-10-07	2014-05-29	University Of Southern California	CBP/catenin antagonists for enhancing asymmetric division of somatic stem cells
GB201315335D0 (en) *	2013-08-29	2013-10-09	Of Singapore	Amino diacids containing peptide modifiers
SG11201601767YA (en) *	2013-09-11	2016-04-28	Prism Pharma Co Ltd	Method of producing pyrazino[2,1-c][1,2,4]triazine compound
US9174998B2 (en) *	2013-12-25	2015-11-03	Eisai R&D Management Co., Ltd.	(6S,9aS)-N-benzyl-6-[(4-hydroxyphenyl)methyl]-4,7-dioxo-8-({6-[3-(piperazin-1-yl)azetidin-1-yl]pyridin-2-yl}methyl)-2-(prop-2-en-1-yl)-octahydro-1H-pyrazino[2,1-c][1,2,4]triazine-1-carboxamide compound
CN107801379B (zh)	2015-06-16	2021-05-25	卫材R&D管理有限公司	抗癌剂
EP3315499B1 (en) *	2015-06-23	2021-04-07	Eisai R&D Management Co., Ltd.	Crystal of (6S,9aS)-N-benzyl-8-({6-[3-(4-ethylpiperazin-1-yl)azetidin-1-yl]pyridin-2-yl}methyl)-6-(2-fluoro-4-hydroxybenzyl)-4,7-dioxo-2-(prop-2-en-1-yl)hexahydro-2H-pyrazino[2,1-c][1,2,4]triazine-1(6H)-carboxamide
GB201511382D0 (en)	2015-06-29	2015-08-12	Imp Innovations Ltd	Novel compounds and their use in therapy
CN108026104B (zh) *	2015-09-18	2021-06-18	国立大学法人鸟取大学	利用低分子化合物的癌及纤维化的抑制和再生促进的效果
WO2017184808A1 (en) *	2016-04-20	2017-10-26	University Of Southern California	Compounds and methods for increasing hematopoiesis
WO2018147275A1 (ja)	2017-02-08	2018-08-16	エーザイ・アール・アンド・ディー・マネジメント株式会社	腫瘍治療用医薬組成物
RU2019134940A (ru)	2017-05-16	2021-06-16	Эйсай Ар Энд Ди Менеджмент Ко., Лтд.	Лечение гепатоцеллюлярной карциномы
CN110950873A (zh) *	2019-12-10	2020-04-03	河南大学	坡尔吲哚的合成新方法
AU2021236240B2 (en) *	2020-03-12	2024-07-25	3+2 Pharma LLC	CBP/catenin signaling pathway inhibitors and uses thereof
WO2021183791A1 (en)	2020-03-12	2021-09-16	City Of Hope	Wnt/cbp/catenin signaling pathway inhibitors and uses thereof
WO2023027888A1 (en) *	2021-08-26	2023-03-02	3+2 Pharma, Llc	Pyrazole-containing cbp/catenin antagonists and uses thereof
GB202209228D0 (en)	2022-06-23	2022-08-10	Univ Strathclyde	Modified amino acids and uses thereof

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3120859A1 (de)	1981-05-26	1982-12-23	Basf Ag, 6700 Ludwigshafen	Dihalogenacetamide, verfahren zu ihrer herstellung und herbizide mittel, die acetanilide als herbizide wirkstoffe und diese dihalogenacetamide als antagonistische mittel enthalten
US5475085A (en)	1991-02-07	1995-12-12	Molecumetics, Ltd.	Conformationally restricted mimetics of beta turns and beta bulges and peptides containing the same
JPH06505486A (ja)	1991-02-07	1994-06-23	モレキュメティクス，リミティド	βターンおよびβバルジのコンフォメーション的に制限された模倣物およびそれらを含有するペプチド
JPH07509723A (ja)	1992-08-06	1995-10-26	モレキュメティクス，リミティド	反転型ターンの立体配座的に拘束されたミメティックスと前者を含有するペプチド
US5446128A (en)	1993-06-18	1995-08-29	The Board Of Trustees Of The University Of Illinois	Alpha-helix mimetics and methods relating thereto
US5693325A (en)	1994-03-15	1997-12-02	Molecumetics, Ltd.	Peptide vaccines and methods relating thereto
US6245764B1 (en)	1995-03-24	2001-06-12	Molecumetics Ltd.	β-sheet mimetics and use thereof as inhibitors of biologically active peptides or proteins
US6020331A (en)	1995-03-24	2000-02-01	Molecumetics, Ltd.	β-sheet mimetics and use thereof as protease inhibitors
US6184223B1 (en)	1995-10-27	2001-02-06	Molecumetics Ltd.	Reverse-turn mimetics and methods relating thereto
US5929237A (en)	1995-10-27	1999-07-27	Molecumetics Ltd.	Reverse-turn mimetics and methods relating thereto
US5840833A (en)	1995-10-27	1998-11-24	Molecumetics, Ltd	Alpha-helix mimetics and methods relating thereto
US6013458A (en)	1995-10-27	2000-01-11	Molecumetics, Ltd.	Reverse-turn mimetics and methods relating thereto
US6117896A (en)	1997-02-10	2000-09-12	Molecumetics Ltd.	Methods for regulating transcription factors
ES2262184T3 (es)	1996-08-05	2006-11-16	Myriad Genetics, Inc.	Utilizacion de mimeticos de hojas beta como inhibidores de proteasa y de kinasa o como inhibidores de factores de transcripcion.
US6451972B1 (en)	1998-11-16	2002-09-17	Sigma-Tau Industrie Farmaceutiche Riunite S.P.A.	Peptido-mimetic compounds containing RGD sequence useful as integrin inhibitors
US6294525B1 (en)	1999-09-01	2001-09-25	Molecumetics Ltd.	Reverse-turn mimetics and methods relating thereto
CA2284459C (en)	1999-10-04	2012-12-11	Neokimia Inc.	Combinatorial synthesis of libraries of macrocyclic compounds useful in drug discovery
US6872825B2 (en)	1999-12-21	2005-03-29	The Procter & Gamble Company	Peptide β-turn mimetic compounds and processes for making them
DE10005631A1 (de)	2000-02-09	2001-08-23	Max Planck Gesellschaft	Arginin-Mimetika als Faktor X¶a¶-Inhibitoren
US7662960B2 (en)	2001-04-26	2010-02-16	Choongwae Pharma Corporation	Beta-strand mimetics and method relating thereto
WO2003006447A2 (en)	2001-07-09	2003-01-23	Pharmacia Italia Spa	Interaction inhibitors of tcf-4 with beta-catenin
US6943157B2 (en) *	2001-10-09	2005-09-13	Myriad Genetics, Inc.	Reverse-turn mimetics and composition and methods relating thereto
US7566711B2 (en) *	2001-10-12	2009-07-28	Choongwae Pharma Corporation	Reverse-turn mimetics and method relating thereto
US20040072831A1 (en)	2001-10-12	2004-04-15	Choongwae Pharma Corporation	Reverse-turn mimetics and method relating thereto
US7576084B2 (en) *	2001-10-12	2009-08-18	Choongwae Pharma Corporation	Reverse-turn mimetics and method relating thereto
ES2310215T3 (es) *	2001-10-12	2009-01-01	Choongwae Pharma Corporation	Estructuras mimeticas de giro inverso y metodo relacionado.
US7671054B1 (en) *	2001-10-12	2010-03-02	Choongwae Pharma Corporation	Reverse-turn mimetics and method relating thereto
US7232822B2 (en) *	2001-10-12	2007-06-19	Choongwae Pharma Corporation	Reverse-turn mimetics and method relating thereto
US6762185B1 (en)	2002-03-01	2004-07-13	Choongwae Pharma Corporation	Compounds useful for treatment of cancer, compositions containing the same, and methods of their use
EP1599480B1 (de)	2003-02-13	2010-06-30	Sanofi-Aventis Deutschland GmbH	Substituierte hexahydro-pyrazino(1,2-a)pyrimidin-4,7-dionderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
KR20050100686A (ko)	2003-02-13	2005-10-19	사노피-아벤티스 도이칠란트 게엠베하	질소-치환된헥사하이드로피라지노[1,2-ａ]피리미딘-4,7-디온 유도체,이의 제조방법 및 의약으로서의 이의 용도
EP1660502A2 (en) *	2003-08-28	2006-05-31	Choongwae Pharma Corporation	MODULATION OF ß-CATENIN/TCF ACTIVATED TRANSCRIPTION
US20070129353A1 (en)	2005-11-08	2007-06-07	Michael Kahn	Alpha-helix mimetics and method relating to the treatment of cancer stem cells
AU2006318327B2 (en)	2005-11-28	2011-08-18	Choongwae Pharma Corporation	Serum-free expansion of cells in culture
KR101671535B1 (ko)	2008-06-06	2016-11-01	가부시키가이샤 프리즘 파마	알파 나선 모방체 및 이와 관련된 방법

2007
- 2007-10-15 US US11/974,941 patent/US7671054B1/en not_active Expired - Fee Related
2008
- 2008-10-15 ES ES08840475.1T patent/ES2541459T3/es active Active
- 2008-10-15 WO PCT/KR2008/006071 patent/WO2009051398A2/en not_active Ceased
- 2008-10-15 PL PL08840475T patent/PL2212330T3/pl unknown
- 2008-10-15 EP EP08839568.6A patent/EP2212329B1/en not_active Not-in-force
- 2008-10-15 EP EP08840475.1A patent/EP2212330B1/en active Active
- 2008-10-15 KR KR1020107010576A patent/KR101542921B1/ko not_active Expired - Fee Related
- 2008-10-15 EP EP08839260.0A patent/EP2212328B1/en not_active Not-in-force
- 2008-10-15 CN CN2008801207859A patent/CN101896485A/zh active Pending
- 2008-10-15 JP JP2010529858A patent/JP5222949B2/ja not_active Expired - Fee Related
- 2008-10-15 RU RU2010119447/04A patent/RU2457210C2/ru active
- 2008-10-15 WO PCT/KR2008/006072 patent/WO2009051399A2/en not_active Ceased
- 2008-10-15 CN CN200880111810.7A patent/CN101827850B/zh not_active Expired - Fee Related
- 2008-10-15 MX MX2010004045A patent/MX2010004045A/es active IP Right Grant
- 2008-10-15 CN CN2008801116629A patent/CN101827849B/zh not_active Expired - Fee Related
- 2008-10-15 JP JP2010529857A patent/JP5222948B2/ja active Active
- 2008-10-15 ES ES08839568.6T patent/ES2509042T3/es active Active
- 2008-10-15 KR KR1020107010682A patent/KR101269420B1/ko active Active
- 2008-10-15 CN CN201310424477.8A patent/CN103539797B/zh active Active
- 2008-10-15 MX MX2010004046A patent/MX2010004046A/es active IP Right Grant
- 2008-10-15 JP JP2010529859A patent/JP5400785B2/ja not_active Expired - Fee Related
- 2008-10-15 CA CA2702461A patent/CA2702461C/en not_active Expired - Fee Related
- 2008-10-15 WO PCT/KR2008/006070 patent/WO2009051397A2/en not_active Ceased
- 2008-10-15 KR KR1020107010575A patent/KR101229504B1/ko not_active Expired - Fee Related
- 2008-10-15 AU AU2008312191A patent/AU2008312191B2/en active Active
- 2008-10-15 RU RU2010119468/04A patent/RU2470024C2/ru active
- 2008-10-15 BR BRPI0818647-2A patent/BRPI0818647B1/pt active IP Right Grant
- 2008-10-15 AU AU2008312193A patent/AU2008312193B2/en not_active Ceased
- 2008-10-15 BR BRPI0818511-5A patent/BRPI0818511B1/pt not_active IP Right Cessation
- 2008-10-15 ES ES08839260.0T patent/ES2622703T3/es active Active
- 2008-10-15 CA CA2701735A patent/CA2701735C/en active Active
- 2008-10-15 US US12/682,881 patent/US8071764B2/en not_active Expired - Fee Related
2009
- 2009-12-29 US US12/649,161 patent/US8138337B2/en not_active Expired - Fee Related
2010
- 2010-04-07 US US12/756,095 patent/US8049008B2/en active Active

Also Published As

Publication number	Publication date
ES2622703T3 (es)	2017-07-07
AU2008312191A1 (en)	2009-04-23
WO2009051399A2 (en)	2009-04-23
CA2701735C (en)	2012-12-11
CA2702461C (en)	2012-12-11
US8049008B2 (en)	2011-11-01
CN101827849A (zh)	2010-09-08
CA2701735A1 (en)	2009-04-23
KR101269420B1 (ko)	2013-05-30
JP5222948B2 (ja)	2013-06-26
MX2010004045A (es)	2010-07-06
RU2010119447A (ru)	2011-11-27
US8138337B2 (en)	2012-03-20
RU2470024C2 (ru)	2012-12-20
EP2212329B1 (en)	2014-07-30
KR101542921B1 (ko)	2015-08-11
EP2212329A4 (en)	2011-11-30
JP2011500667A (ja)	2011-01-06
EP2212328A2 (en)	2010-08-04
US7671054B1 (en)	2010-03-02
CA2702461A1 (en)	2009-04-23
US20100222303A1 (en)	2010-09-02
CN101896485A (zh)	2010-11-24
WO2009051398A3 (en)	2009-06-04
BRPI0818647A2 (pt)	2015-04-07
KR20100085102A (ko)	2010-07-28
WO2009051397A3 (en)	2009-06-04
EP2212328A4 (en)	2011-11-30
RU2010119468A (ru)	2011-11-27
ES2541459T3 (es)	2015-07-20
MX2010004046A (es)	2010-06-25
CN103539797A (zh)	2014-01-29
EP2212328B1 (en)	2017-01-25
AU2008312191B2 (en)	2012-07-05
EP2212330A2 (en)	2010-08-04
WO2009051399A3 (en)	2009-06-04
RU2457210C2 (ru)	2012-07-27
KR101229504B1 (ko)	2013-02-04
AU2008312193B2 (en)	2012-10-18
CN103539797B (zh)	2016-05-18
PL2212330T3 (pl)	2015-09-30
CN101827850B (zh)	2014-03-12
US20100228027A1 (en)	2010-09-09
US8071764B2 (en)	2011-12-06
JP5400785B2 (ja)	2014-01-29
WO2009051397A2 (en)	2009-04-23
US20100240662A1 (en)	2010-09-23
KR20100099116A (ko)	2010-09-10
CN101827850A (zh)	2010-09-08
JP5222949B2 (ja)	2013-06-26
EP2212329A2 (en)	2010-08-04
BRPI0818647B1 (pt)	2021-10-26
WO2009051398A2 (en)	2009-04-23
EP2212330B1 (en)	2015-04-08
KR20100085107A (ko)	2010-07-28
JP2011500668A (ja)	2011-01-06
AU2008312193A1 (en)	2009-04-23
BRPI0818511B1 (pt)	2021-09-21
CN101827849B (zh)	2013-07-24
ES2509042T3 (es)	2014-10-16
EP2212330A4 (en)	2011-11-30
WO2009051397A9 (en)	2010-05-27
JP2011500666A (ja)	2011-01-06

Publication	Publication Date	Title
BRPI0818511A2 (pt)	2015-06-16	Novos compostos de miméticos de giro reverso e uso dos mesmos (1)
BRPI0808013A2 (pt)	2014-06-17	Compostos de quinoxalina e uso dos mesmos
PT2124638T (pt)	2017-03-13	Composição de aperfeiçoamento de desempenho e utilização da mesma
BRPI0716327A2 (pt)	2014-03-04	Composto de fenilpropionamida e uso
BRPI0813355A2 (pt)	2014-12-30	Compostos de quinazolinona e métodos de uso dos mesmos
BRPI0815811A2 (pt)	2015-02-18	Derivados de indol substituído e métodos de uso dos mesmos
CR10743A (es)	2009-06-05	Derivados de azaadamantano y metodos de uso de los mismos
BRPI0820457A2 (pt)	2015-06-16	Fluidos de ruptura e métodos de uso dos mesmos
BRPI0720625A2 (pt)	2014-03-25	Derivados de indol de 4,5-anel anulados e métodos de uso dos mesmos
BRPI0909954A2 (pt)	2015-11-03	"diazacarbazóis e métodos de uso"
BRPI0923725A2 (pt)	2015-08-04	"compostos absorventes de uv trifuncionais e uso dos mesmos".
CR10725A (es)	2009-05-12	Compuestos de pirazolina y su uso y composiones farmaceuticas
FI20075532A0 (fi)	2007-07-10	Uusia esteraaseja ja niiden käyttö
BRPI0807495A2 (pt)	2014-05-20	Adjuvantes e métodos de emrpego dos mesmos
BRPI0810522A2 (pt)	2014-10-21	Mimétricos diazo bicíclicos de smac e uso dos mesmos.
BRPI0813770A2 (pt)	2014-12-30	Composição, e, uso de uma composição
BRPI0813457A2 (pt)	2014-12-23	Composto de organoenxofre contendo halogênio e uso do mesmo
DK1954953T3 (da)	2011-09-12	Gevindforbindelser med coatinger med høj og lav friktion
BRPI0813627A2 (pt)	2014-12-23	Peptídio antimicrobiano, composições e métodos de uso
BRPI0614205A2 (pt)	2016-11-22	composto, composição farmacêutica, e, uso de composto
BR112012003661A2 (pt)	2017-04-25	"compostos de biarila e métodos de uso dos mesmos."
BRPI0821668A2 (pt)	2015-06-16	Uso
BRPI0907365A2 (pt)	2015-07-14	Composição antimicrobiana e uso
BRPI0813955A2 (pt)	2017-05-09	composições terapêuticas e o uso das mesmas
SMT201500218B (it)	2015-10-30	Composti aril-fenil-solfonammido-cicloalchile e loro uso

Legal Events

Date	Code	Title	Description
2018-04-17	B06F	Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
2020-06-23	B07D	Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]	Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.
2020-11-17	B07E	Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
2020-12-01	B06U	Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
2021-03-30	B06A	Patent application procedure suspended [chapter 6.1 patent gazette]
2021-07-06	B09A	Decision: intention to grant [chapter 9.1 patent gazette]
2021-09-21	B16A	Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]	Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 15/10/2008, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO.
2022-08-09	B21F	Lapse acc. art. 78, item iv - on non-payment of the annual fees in time	Free format text: REFERENTE A 14A ANUIDADE.
2022-11-29	B24J	Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)	Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2692 DE 09-08-2022 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.